Table 3: Prevalence of High-Risk (HR), Putative High-Risk (pHR) and Low-Risk (LR) HPV Types in Cervical Smears Taken from Women with Negative Histopathologic Diagnosis and in Patients with CIN and CC

HPV Type (*) Negative Pathology n (%) (**) CIN I n (%) (**) CIN II n (%) (**) CIN III n (%) (**) Cervical Cancer n (%) (**) Total by HPV Type n (%) (**) Total by HPV Risk Group n (%) (***)
HR 16 31 (75.6) 45 (80.3) 14 (87.5) 31 (93.9) 14 (100) 135 (84.4) 154 (96.25%)
18 22 (53.6) 39 (69.6) 10 (62.5) 22 (66.6) 4 (28.5) 97 (60.6)
31 1 (2.4) 2 (3.6) 2 (12.5) 2 (6) 0 (0) 7 (4.4%)
33 1 (2.4) 3 (5.3) 0 (0) 3 (9) 0 (0) 7 (4.4%)
35 3 (7.3) 4 (7.1) 0 (0) 1 (3) 0 (0) 8 (5%)
39 6 (14.6) 2 (3.6) 0 (0) 4 (12.1) 0 (0) 12 (7.5%)
45 2 (4.9) 5 (8.9) 3 (18.7) 2 (6) 1 (7.1) 13 (8.1%)
51 5 (12.2) 7 (12.5) 1 (6.2) 1 (3) 0 (0) 14 (8.7%)
52 3 (7.3) 6 (10.7) 2 (12.5) 4 (12.1) 2 (14.3) 17 (10.6%)
56 9 (22) 15 (26.7) 2 (12.5) 0 (0) 1 (7.1) 27 (16.9)
58 1 (2.4) 7 (12.5) 1 (6.2) 2 (6) 2 (14.3) 13 (8.1%)
59 0 (0) 2 (3.6) 0 (0) 1 (3) 1 (7.1) 4 (2.5%)
68a 2 (4.9) 2 (3.6) 0 (0) 0 (0) 0 (0) 4 (2.5%)
68b 0 (0) 3 (5.3) 0 (0) 3 (9) 0 (0) 6 (3.7%)
73 0 (0) 0 (0) 1 (6.2) 2 (6) 0 (0) 3 (1.9%)
82 2 (4.9) 3 (5.3) 0 (0) 0 (0) 0 (0) 5 (3.1%)
pHR 53 2 (4.9) 2 (3.6) 0 (0) 3 (9) 1 (7.1) 8 (5%) 22 (13.75%)
66 4 (9.7) 6 (10.7) 2 (12.5) 5 (15.1) 0 (0) 17 (10.6%)
LR 6 2 (4.9) 1 (1.8) 3 (18.7) 0 (0) 3 (21.4) 9 (5.6%) 50 (31.25%)
11 0 (0) 2 (3.6) 2 (12.5) 1 (3) 0 (0) 5 (3.1%)
30 2 (4.9) 3 (5.3) 1 (6.2) 1 (3) 0 (0) 7 (4.4%)
42 0 (0) 5 (8.9) 1 (6.2) 2 (6) 1 (7.1) 9 (5.6%)
43 2 (4.9) 1 (1.8) 0 (0) 0 (0) 0 (0) 3 (1.9%)
44 0 (0) 4 (7.1) 0 (0) 0 (0) 0 (0) 4 (2.5%)
67 1 (2.4) 1 (1.8) 0 (0) 1 (3) 0 (0) 3 (1.9%)
69 1 (2.4) 0 (0) 2 (12.5) 1 (3) 1 (7.1) 5 (3.1%)
70 2 (4.9) 4 (7.1) 0 (0) 1 (3) 1 (7.1) 8 (5%)

(*) A total of 28 HPV types were tested of which the 27 types shown could be detected either as unique or combined double/multiple infections. The pHR-HPV type 26, which was also tested, resulted negative in all samples analyzed.
(**) Percentages relative to the total number of cases in each group.
(***) Percentages relative to the total number of participants in the study.